chrX-32463545-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_004006.3(DMD):c.3326A>T(p.Asn1109Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000188 in 1,198,708 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 80 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00040 ( 0 hom., 19 hem., cov: 23)
Exomes 𝑓: 0.00017 ( 0 hom. 61 hem. )
Consequence
DMD
NM_004006.3 missense
NM_004006.3 missense
Scores
2
7
7
Clinical Significance
Conservation
PhyloP100: 6.09
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant X-32463545-T-A is Benign according to our data. Variant chrX-32463545-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 201760.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=3, Uncertain_significance=2}. Variant chrX-32463545-T-A is described in Lovd as [Benign]. Variant chrX-32463545-T-A is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 19 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.3326A>T | p.Asn1109Ile | missense_variant | 25/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.3326A>T | p.Asn1109Ile | missense_variant | 25/79 | 1 | NM_004006.3 | ENSP00000354923 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000402 AC: 45AN: 112033Hom.: 0 Cov.: 23 AF XY: 0.000555 AC XY: 19AN XY: 34207
GnomAD3 genomes
AF:
AC:
45
AN:
112033
Hom.:
Cov.:
23
AF XY:
AC XY:
19
AN XY:
34207
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000210 AC: 34AN: 161551Hom.: 0 AF XY: 0.000160 AC XY: 8AN XY: 50139
GnomAD3 exomes
AF:
AC:
34
AN:
161551
Hom.:
AF XY:
AC XY:
8
AN XY:
50139
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000166 AC: 180AN: 1086675Hom.: 0 Cov.: 28 AF XY: 0.000172 AC XY: 61AN XY: 354223
GnomAD4 exome
AF:
AC:
180
AN:
1086675
Hom.:
Cov.:
28
AF XY:
AC XY:
61
AN XY:
354223
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000402 AC: 45AN: 112033Hom.: 0 Cov.: 23 AF XY: 0.000555 AC XY: 19AN XY: 34207
GnomAD4 genome
AF:
AC:
45
AN:
112033
Hom.:
Cov.:
23
AF XY:
AC XY:
19
AN XY:
34207
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
19
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:6
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | DMD: BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 04, 2019 | The DMD c.3326A>T; p.Asn1109Ile variant (rs200596739), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 201760). This variant is found in the general population with an overall allele frequency of 0.02% (48/183570 alleles, including 11 hemizygotes) in the Genome Aggregation Database. The asparagine at codon 1109 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: damaging) predict conflicting effects of this variant on protein structure/function. However, due to limited information, the clinical significance of the p.Asn1109Ile variant is uncertain at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 07, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2020 | - - |
Dilated cardiomyopathy 3B Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 10, 2018 | The p.Asn1109Ile variant in DMD is classified as benign because it has been iden tified in 0.13% (23/17581) of Finnish chromosomes and 12 homozygotes by gnomAD ( http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. - |
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;.;D
REVEL
Uncertain
Sift
Benign
.;T;.;T
Sift4G
Benign
T;T;T;T
Polyphen
1.0
.;D;.;.
Vest4
MutPred
0.60
.;.;Loss of disorder (P = 0.0436);Loss of disorder (P = 0.0436);
MVP
MPC
0.13
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at